The AI in Drug Discovery Market is being driven by the increasing adoption of machine learning technologies across pharmaceutical research. Machine learning can process large datasets and identify patterns that support target discovery, molecular screening, and candidate evaluation.

Target identification is one important application. AI systems can analyze biological and molecular information to identify potential targets associated with specific diseases. This can help researchers prioritize targets for further laboratory investigation.

Lead optimization is another major application. Machine learning models can help researchers predict molecular characteristics and identify compounds with potentially desirable properties, supporting more efficient candidate selection.

Natural language processing can also contribute to drug discovery by analyzing scientific publications, clinical information, patents, and other sources of biomedical knowledge. This allows researchers to extract relevant information from large volumes of text.

According to Market Research Future, machine learning is the dominant technology segment, while deep learning is an emerging technology with increasing applications in drug target identification and molecular prediction.